-
Cy5 NHS ester(Et): Practical Labeling Guide
2026-08-24
Cy5 NHS ester(Et) is a water-soluble, amine-reactive fluorescent reagent for attaching Cy5 to proteins, peptides, and other biomolecules through stable amide bonds. It is suited to aqueous protein fluorescent labeling, immunofluorescence staining, flow cytometry, and fluorescence microscopy, but not to ethanol-based workflows or long-term storage of prepared solutions.
-
CH 223191: A Causal Tool for AhR Toxicology
2026-08-24
CH 223191 is an aryl hydrocarbon receptor antagonist that helps distinguish AhR pathway activation from downstream reproductive toxicity. This article translates ovarian follicle findings into a practical, causality-focused framework for environmental toxicology research and assay design.
-
Carbapenemase Gene Spread in CREC Hospitals
2026-08-23
The 2025 BMC Microbiology study combines gene localization, conjugation testing, mobile-element profiling, and ERIC-PCR to examine carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae from eight Guangdong teaching hospitals. Its findings indicate that blaNDM-1 is frequently plasmid associated, readily transferable under laboratory conditions, and linked to multidrug resistance, while clonal and interhospital patterns complicate infection-control interpretation.
-
HDAC3, TPM3 Khib, and Abnormal Vasoconstriction
2026-08-22
This study identifies HDAC3-mediated loss of 2-hydroxyisobutyrylation at TPM3 Lys141 as a molecular pathway linking phenylephrine signaling to excessive vascular smooth muscle contraction. By combining coimmunoprecipitation, aortic-ring tension assays, computational modeling, and mutation-based validation, the work provides mechanistic evidence that TPM3 Khib is a potential control point in hypertensive vascular dysfunction.
-
Sodium Picosulfate Research Workflows
2026-08-22
Sodium Picosulfate provides a controllable way to study intestinal water handling, stool-transit phenotypes, and electrolyte-related readouts in translational models. This workflow also shows how to use it as a carefully bounded gut perturbation when investigating gut–liver–brain biology, without overstating evidence for direct neuroinflammatory effects.
-
SIRT4–GDH Control of Glutamine Metabolism in Fibrosis
2026-08-21
The reference study identifies a metabolic vulnerability in activated hepatic stellate cells: glutaminolysis, controlled in part by the mitochondrial SIRT4–GDH axis, supports fibrogenic activity. Its pharmacological and genetic evidence suggests that restraining glutamate conversion to α-ketoglutarate may reduce stellate-cell proliferation and liver fibrosis, while also defining important boundaries for future translation.
-
Protein A/G Magnetic Beads: Practical Workflow
2026-08-20
Protein A/G Magnetic Beads (SKU K1305) support Fc-directed antibody purification, immunoprecipitation, co-immunoprecipitation, and chromatin immunoprecipitation from complex biological samples. They should be used as research reagents with assay-specific optimization; the supplied information does not establish diagnostic performance, universal antibody compatibility, binding capacity, or quantitative recovery.
-
Epoxomicin for Proteasome Pathway Research
2026-08-20
Epoxomicin provides a selective, irreversible way to test whether proteasomal degradation controls RIPK3-dependent inflammation, while also supporting broader protein quality-control studies. This workflow combines mechanistic cell assays, degradation readouts, and practical handling guidance for reproducible proteasome inhibitor experiments.
-
Chlorpromazine HCl in Endocytosis Workflows
2026-08-19
Chlorpromazine HCl supports controlled dopamine receptor inhibition while offering a useful pharmacological perturbation for cell-uptake experiments. Paired with the reference study’s alternating-current stimulation workflow, it helps separate receptor-linked effects from physical enhancement of nanoparticle endocytosis.
-
UBR1 and UBR2 in Mammalian ER Stress Sensing
2026-08-19
The reference study identifies the N-recognin E3 ligases UBR1 and UBR2 as stress-responsive regulators of mammalian protein quality control. Its findings connect the N-degron pathway with ER-associated degradation by showing that UBR1 and UBR2 stability increases during ER stress, whereas their loss sensitizes cells to ER stress-induced apoptosis.
-
Zosuquidar (LY335979) for MDR Assays
2026-08-18
Zosuquidar (LY335979) 3HCl gives researchers a selective way to test whether P-glycoprotein efflux drives chemotherapy failure. This practical guide connects cell-based sensitization, transporter assays, pharmacokinetic controls, and troubleshooting for AML, lymphoma, and solid-tumor models.
-
Smoothened in Honeybee Olfaction: Guo et al. 2024
2026-08-18
Guo et al. characterize Smoothened (Smo) in Apis mellifera and connect its activity to olfactory receptor expression, antennal electrophysiology, and odor-guided behavior. The study provides pharmacological evidence that Hedgehog signaling contributes to insect sensory regulation while identifying important limits for translating these findings to mammalian regenerative research.
-
HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus
2026-08-17
The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus is a Cy3 RNA labeling kit for generating randomly Cy3-modified RNA probes by T7 in vitro transcription. It is intended for research applications such as in situ hybridization and Northern blot hybridization, not for diagnostic, therapeutic, or clinical use.
-
Lambda Protein Phosphatase for BMAL1 Validation
2026-08-17
Use Lambda Protein Phosphatase to test whether BMAL1 phosphorylation changes antibody recognition, condensate formation, or circadian transcriptional output. This workflow combines a defined Mn²⁺-dependent dephosphorylation step with matched biochemical, imaging, and functional controls.
-
Rapakinin Signaling in Hypertensive Rat Arteries
2026-08-16
The reference study identifies rapakinin, the rapeseed-derived tripeptide Arg-Ile-Tyr, as an endothelium-dependent vasorelaxant in spontaneously hypertensive rat mesenteric arteries. Its activity was linked principally to sequential prostaglandin I2–IP receptor and CCK1 receptor signaling rather than nitric oxide synthase inhibition, refining the mechanistic interpretation of food-derived antihypertensive peptides.